FineTech Pharmaceutical

Established in 1990 by Dr. Arie Gutman, FineTech has a proven track record of successfully developing and manufacturing low volume, high value complex APIs. Our International team of highly qualified scientists and engineers work in our state-of-the-art FDA approved facility to meet our customers' needs. We develop novel patented processes, find "by-passes" to existing patents, develop new polymorphs, prepare DMFs and manufacture complex APIs. In several cases, our skills and efforts enabled our customers to become the first (and sometimes the only) generic company to launch products with high entry barriers. Our customers include leading generic companies in the USA, Canada, Europe and Israel.